Home
Conditions
Pancreatic Neoplasms

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

144 public trials 38 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Not yet recruiting

Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts

NCT06162468

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations: Te Whatu Ora Waitematā Auckland, New Zealand

Te Whatu Ora Waikato Hamilton, New Zealand

View Trial Details

Not yet recruiting

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

NCT06573398

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS

NCT05621824

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms

NCT05316480

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +10 more
Locations: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Enrolling by invitation

Patients With High-grade Pancreatic Neuroendocrine Tumors

NCT07121478

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +15 more
Locations: National Cancer Center Goyang-si, Gyeonggi-do, South Korea

View Trial Details

Active, not recruiting

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

NCT06447662

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +29 more
Locations: Highlands Oncology Group, PA Fayetteville, Arkansas, United States

Highlands Oncology Group, PA Rogers, Arkansas, United States

Highlands Oncology Group Springdale, Arkansas, United States

City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States

View all 27 locations

View Trial Details

Active, not recruiting

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

NCT03375320

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +42 more
Locations: Katmai Oncology Group Anchorage, Alaska, United States

Kingman Regional Medical Center Kingman, Arizona, United States

Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 432 locations

View Trial Details

Active, not recruiting

Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation

NCT07817225

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +10 more
Locations: IRCCS San Raffaele Milan, MI, Italy

View Trial Details

Active, not recruiting

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

NCT03074513

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +63 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients

NCT05037461

Conditions: Adenoma, Adenoma, Islet Cell, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations: UMC Utrecht Utrecht, Netherlands

View Trial Details

Pancreatic Neoplasms

Pancreatic Neoplasms trial results

Related conditions